​

Clearside Biomedical (CLSD) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Clearside Biomedical Revenue Highlights

0

Latest Revenue (Q)

$2.33M

Main Segment (Y)

License

Clearside Biomedical Revenue by Period

Clearside Biomedical Revenue by Year

DateRevenueChange
2024-12-31--100.00%
2023-12-31$8.23M519.89%
2022-12-31$1.33M-95.51%
2021-12-31$29.57M274.65%
2020-12-31$7.89M263.28%
2019-12-31$2.17M7143.33%
2018-12-31$30.00K-91.30%
2017-12-31$345.00K-33.65%
2016-12-31$520.00K100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31--

Clearside Biomedical generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Clearside Biomedical Revenue by Quarter

DateRevenueChange
2025-03-31$2.33M661.44%
2024-12-31$306.00K-70.52%
2024-09-30$1.04M1053.33%
2024-06-30$90.00K-60.87%
2024-03-31$230.00K-96.38%
2023-12-31$6.34M638.65%
2023-09-30$859.00K-15.62%
2023-06-30$1.02M25350.00%
2023-03-31$4.00K-98.79%
2022-12-31$330.00K24.06%
2022-09-30$266.00K-30.73%
2022-06-30$384.00K10.66%
2022-03-31$347.00K-98.65%
2021-12-31$25.69M735.62%
2021-09-30$3.07M294.10%
2021-06-30$780.00K2194.12%
2021-03-31$34.00K209.09%
2020-12-31$11.00K-99.68%
2020-09-30$3.43M869.49%
2020-06-30$354.00K-91.36%
2020-03-31$4.10M110.97%
2019-12-31$1.94M1277.30%
2019-09-30$141.00K213.33%
2019-06-30$45.00K-
2019-03-31$45.00K50.00%
2018-12-31$30.00K100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--100.00%
2017-12-31$55.00K-64.52%
2017-09-30$155.00K19.23%
2017-06-30$130.00K2500.00%
2017-03-31$5.00K-
2016-12-31$5.00K-
2016-09-30$5.00K-
2016-06-30$5.00K-99.01%
2016-03-31$505.00K100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31--

Clearside Biomedical generated $2.33M in revenue during Q1 2025, up 661.44% compared to the previous quarter, and up 36.72% compared to the same period a year ago.

Clearside Biomedical Revenue Breakdown

Clearside Biomedical Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
License$1.70M$8.20M$1.30M--
Product and Service, Other$700.00K----
Other Agreement---$13.00K$200.00K

Clearside Biomedical's latest annual revenue breakdown by segment (product or service), as of Dec 24: License (70.83%), and Product and Service, Other (29.17%).

Quarterly Revenue by Product

Product/ServiceJun 20Sep 19Jun 19Mar 19
License And Service$200.00K$141.00K$45.00K$45.00K

Clearside Biomedical's latest quarterly revenue breakdown by segment (product or service), as of Jun 20: License And Service (100.00%).

Clearside Biomedical Revenue Breakdown by Country

Quarterly Revenue by Country

CountryJun 20Sep 19Jun 19Mar 19
License And Service$200.00K$141.00K$45.00K$45.00K

Clearside Biomedical's latest quarterly revenue breakdown by geography, as of Jun 20: License And Service (100.00%).

Clearside Biomedical Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
SABSSAB Biotherapeutics$2.24M-
LSTALisata Therapeutics$1.00M-
RLYBRallybio$636.00K$212.00K
APLMApollomics--
AIMDAinos-$106.21K
ALLRAllarity Therapeutics--
CINGCingulate--
PCSAProcessa Pharmaceuticals--
CLSDClearside Biomedical-$2.33M
HOTHHoth Therapeutics--
LNAILunai Bioworks--

CLSD Revenue FAQ

What is Clearside Biomedical’s yearly revenue?

Clearside Biomedical's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $8.23M, representing an increase of 519.89% compared to 2022. CLSD's yearly revenue for 2022 was $1.33M, representing a decrease of -95.51% compared to 2021.

What is Clearside Biomedical’s quarterly revenue?

Clearside Biomedical's quarterly revenue for Q1 2025 was $2.33M, a 661.44% increase from the previous quarter (Q4 2024), and a 913.04% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $306K, a -70.52% decrease from the previous quarter (Q3 2024), and a -95.18% decrease year-over-year (Q4 2023). CLSD's quarterly revenue for Q3 2024 was $1.04M, a 1053.33% increase from the previous quarter (Q2 2024), and a 20.84% increase year-over-year (Q3 2023).

What is Clearside Biomedical’s revenue growth rate?

Clearside Biomedical's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

What are Clearside Biomedical’s revenue streams?

Clearside Biomedical's revenue streams in c 24 are License, and Product and Service, Other. License generated $1.7M in revenue, accounting 70.83% of the company's total revenue, down -79.27% year-over-year. Product and Service, Other generated $700K in revenue, accounting 29.17% of the company's total revenue

What is Clearside Biomedical’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Clearside Biomedical was License. This segment made a revenue of $1.7M, representing 70.83% of the company's total revenue.